PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
04-Mar-2025 Delivering the NHS 10-Year Plan will require a fourth ‘shift’ says ABPI ABPI
04-Mar-2025 Preliminary figures for Medios AG 2024: Significant increase in earnings and margins – positive outlook for 2025 Medios AG
04-Mar-2025 Evotec Announces Key Progress in Neuroscience Collaboration with Bristol Myers Squibb Evotec SE
04-Mar-2025 AEVIS VICTORIA SA – Strong growth in 2024 revenue and improved profitability AEVIS VICTORIA SA
03-Mar-2025 Fresenius SE & Co. KGaA: Fresenius announces its intention to reduce its stake in Fresenius Medical Care AG from currently around 32.2% to no less than 25% plus one share Fresenius SE & Co. KGaA
03-Mar-2025 Amazon Filters flags pharmaceuticals reach at New York’s InterPhex Amazon Filters Ltd
03-Mar-2025 Changes in the Supervisory Board and Management Board of Pentixapharm Holding AG Pentixapharm Holding AG
03-Mar-2025 Colorectal Cancer Awareness Month: Mainz Biomed Advocates for a Shift from Screening to Prevention Mainz BioMed N.V.
03-Mar-2025 FYB202/Otulfi® (ustekinumab-aauz), a biosimilar to Stelara®, launched in the United States and the European Union Formycon AG
03-Mar-2025 Immunic to Participate in Scientific and Investor Conferences in March Immunic AG
03-Mar-2025 Novo Holdings and TA Associates partner with Biocomposites to drive next chapter of its growth Novo Holdings
03-Mar-2025 Kelso Pharma’s European growth story continues with appointment of new General Manager in Italy Kelso Pharma
03-Mar-2025 AbbVie and Gubra Announce License Agreement to Develop an Amylin Analog for the Treatment of Obesity AbbVie
03-Mar-2025 Phase III study shows Xolair may be more effective with fewer side effects than oral immunotherapy for the treatment of food allergies Roche
03-Mar-2025 Depemokimab applications accepted for review by the US FDA for asthma with type 2 inflammation and for chronic rhinosinusitis with nasal polyps (CRSwNP) GSK
03-Mar-2025 Depemokimab delivers clinically meaningful and statistically significant improvements for patients with chronic rhinosinusitis with nasal polyps (CRSwNP) GSK
03-Mar-2025 Imfinzi-based perioperative regimen recommended for approval in the EU by CHMP for resectable non-small cell lung cancer AstraZeneca
28-Feb-2025 Viromed Medical AG reaches milestone for cooperation with multinational corporation Viromed Medical AG
28-Feb-2025 Orchard Therapeutics Announces Reimbursement Agreement in Spain Orchard Therapeutics
28-Feb-2025 Nxera Pharma Enters Agreement with Holling to Commercialize Daridorexant in Taiwan Nxera Pharma